TECH — BIO-TECHNE Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for BIO-TECHNE, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	140	263	285	168	73.4
Depreciation
Deferred Taxes
Non-Cash Items	123	23.8	-18.1	68.7	144
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	29.3	-69.5	-90.6	-10.1	11.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities	352	325	254	299	288
Capital Expenditures	-44.3	-44.9	-38.2	-62.9	-31
Purchase of Fixed Assets
Other Investing Cash Flow Items	-199	-51.9	-227	-140	-4.18
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-244	-96.9	-266	-203	-35.2
Financing Cash Flow Items	-19.3	-23.4	-31.4	-21.9	-6.52
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-62.6	-243	22.6	-122	-254
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	52.5	-26.5	8	-28.8	10.4